EA201991760A2 - ACC INHIBITORS AND THEIR APPLICATIONS - Google Patents

ACC INHIBITORS AND THEIR APPLICATIONS

Info

Publication number
EA201991760A2
EA201991760A2 EA201991760A EA201991760A EA201991760A2 EA 201991760 A2 EA201991760 A2 EA 201991760A2 EA 201991760 A EA201991760 A EA 201991760A EA 201991760 A EA201991760 A EA 201991760A EA 201991760 A2 EA201991760 A2 EA 201991760A2
Authority
EA
Eurasian Patent Office
Prior art keywords
applications
acc inhibitors
acc
inhibitors
methods
Prior art date
Application number
EA201991760A
Other languages
Russian (ru)
Other versions
EA201991760A3 (en
Inventor
Джеральдин С. Харриман
Крейг Е. Массе
Джеймс Харвуд
Сатеш Бхат
Джереми Роберт Гринвуд
Original Assignee
Джилид Аполло, Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Аполло, Ллс filed Critical Джилид Аполло, Ллс
Publication of EA201991760A2 publication Critical patent/EA201991760A2/en
Publication of EA201991760A3 publication Critical patent/EA201991760A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

В настоящем изобретении предложены соединения, подходящие для применения в качестве ингибиторов ацетил-КоА карбоксилазы (АСС), содержащие их композиции и способы, в которых их применяют.The present invention provides compounds suitable for use as acetyl CoA carboxylase (ACC) inhibitors, compositions containing them and methods in which they are used.

EA201991760A 2012-07-25 2012-11-09 ACC INHIBITORS AND THEIR APPLICATIONS EA201991760A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261675513P 2012-07-25 2012-07-25

Publications (2)

Publication Number Publication Date
EA201991760A2 true EA201991760A2 (en) 2019-12-30
EA201991760A3 EA201991760A3 (en) 2020-03-31

Family

ID=69061903

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991760A EA201991760A3 (en) 2012-07-25 2012-11-09 ACC INHIBITORS AND THEIR APPLICATIONS

Country Status (1)

Country Link
EA (1) EA201991760A3 (en)

Also Published As

Publication number Publication date
EA201991760A3 (en) 2020-03-31

Similar Documents

Publication Publication Date Title
EA201490826A1 (en) ACC INHIBITORS AND THEIR APPLICATIONS
EA201890749A1 (en) ACETHYL-COA-CARBOXYLASE INHIBITORS (ACC) AND THEIR APPLICATION
EA201591961A1 (en) ACC INHIBITORS AND THEIR APPLICATION
EA201591959A1 (en) ACC INHIBITORS AND THEIR APPLICATION
EA201591960A1 (en) ACC INHIBITORS AND THEIR APPLICATION
CO2018005381A2 (en) AC ester inhibitors and uses thereof
EA201591962A1 (en) ACC INHIBITORS AND THEIR APPLICATION
CO2018005369A2 (en) Triazole acc inhibitors and uses thereof
EA201591137A1 (en) MK2 INHIBITORS AND THEIR APPLICATIONS
CO2018000668A2 (en) New bicyclic compounds as dual atx / ca inhibitors
CR20150462A (en) ERK INHIBITORS AND THEIR USES
CO2018000631A2 (en) Bicyclic compounds as atx inhibitors
EA201591420A1 (en) Heteroaryl Compounds and Their Use
MX2016003843A (en) Irak inhibitors and uses thereof.
EA201492223A1 (en) NEW DIAZASPYROCYCLO ALKANES AND AZASPIROCYCLO ALKANES
EA201400833A1 (en) NEW INDOLESINE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201790380A1 (en) MK2 INHIBITORS AND THEIR APPLICATIONS
EA201690613A1 (en) IMPROVED COMPOSITIONS BASED ON ADENOVIRUSES
EA201591728A1 (en) HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION
EA201590887A1 (en) COMPOSITION
EA201690764A1 (en) INHIBITOR GRELIN-O-Aciltransferase
EA201892509A1 (en) ANTIBODIES TO HEMAGGLUTININ AND METHODS OF APPLICATION
EA201491647A1 (en) BASED ON ARILETHER KINAZ INHIBITORS
EA201600124A1 (en) NEW INDOLESINE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201500801A1 (en) BENZOHINOLONE INHIBITORS VMAT2